Terms: = Sarcomas AND MSH2, COCA1, 4436, ENSG00000095002, HNPCC, FCC1, HNPCC1, P43246
66 results:
1. [Clinicopathological and gene mutation characteristics of uterine carcinosarcoma].
Tu J; Xu JZ; Zhang YS; Deng LF
Zhonghua Yi Xue Za Zhi; 2023 Jun; 103(24):1864-1867. PubMed ID: 37357193
[TBL] [Abstract] [Full Text] [Related]
2. Special features of sarcomas developed in patients with Lynch syndrome: A systematic review.
Poumeaud F; Valentin T; Vande Perre P; Jaffrelot M; Bonnet D; Chibon F; Chevreau C; Selves J; Guimbaud R; Fares N
Crit Rev Oncol Hematol; 2023 Aug; 188():104055. PubMed ID: 37301271
[TBL] [Abstract] [Full Text] [Related]
3. Germline drivers of gynecologic carcinosarcomas.
Sia TY; Gordhandas SB; Birsoy O; Kemel Y; Maio A; Salo-Mullen E; Sheehan M; Hensley ML; Rubinstein M; Makker V; Grisham RN; O'Cearbhaill RE; Roche KL; Mueller JJ; Leitao MM; Sonoda Y; Chi DS; Abu-Rustum NR; Berger MF; Ellenson LH; Latham A; Stadler Z; Offit K; Aghajanian C; Weigelt B; Mandelker D; Liu YL
Gynecol Oncol; 2023 Jul; 174():34-41. PubMed ID: 37149903
[TBL] [Abstract] [Full Text] [Related]
4. The expression of programmed death-ligand 1 and programmed death-ligand 2 in endometrial carcinosarcoma: Correlation with mismatch repair protein expression status, tumor-infiltrating lymphocyte infiltration, and clinical outcomes.
Atılgan AO; Tepeoğlu M; Özen Ö; Reyhan ANH; Ayhan A
Ann Diagn Pathol; 2023 Aug; 65():152137. PubMed ID: 37060883
[TBL] [Abstract] [Full Text] [Related]
5. Mediastinal Myxofibrosarcoma Harboring Loss-of-Function
Jia L; Hwang H; De Las Casas L
Int J Surg Pathol; 2023 Dec; 31(8):1605-1609. PubMed ID: 37013349
[TBL] [Abstract] [Full Text] [Related]
6. Pharmacogenetics of the Primary and Metastatic Osteosarcoma: Gene Expression Profile Associated with Outcome.
Trujillo-Paolillo A; Tesser-Gamba F; Seixas Alves MT; Filho RJG; Oliveira R; Petrilli AS; Toledo SRC
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982681
[TBL] [Abstract] [Full Text] [Related]
7. Inflammatory leiomyosarcoma/rhabdomyoblastic tumor: A report of two cases with novel genetic findings.
Sukhanova M; Obeidin F; Streich L; Alexiev BA
Genes Chromosomes Cancer; 2022 Nov; 61(11):653-661. PubMed ID: 35655404
[TBL] [Abstract] [Full Text] [Related]
8. FAT1 and msh2 Are Predictive Prognostic Markers for Chinese Osteosarcoma Patients Following Chemotherapeutic Treatment.
Zhou C; Sun Y; Gong Z; Li J; Zhao X; Yang Q; Yu H; Ye J; Liang J; Jiang L; Zhang D; Shen Z; Zheng S
J Bone Miner Res; 2022 May; 37(5):885-895. PubMed ID: 35279875
[TBL] [Abstract] [Full Text] [Related]
9. A Case of Pheochromocytoma as a Subsequent Neoplasm in a Survivor of Childhood Embryonal Rhabdomyosarcoma.
Rodwin RL; Janardan SK; Hofstatter EW; Kadan-Lottick NS
J Pediatr Hematol Oncol; 2022 Mar; 44(2):e585-e588. PubMed ID: 35200227
[TBL] [Abstract] [Full Text] [Related]
10. Synchronous lung and multiple soft tissue metastases developed from osteosarcoma of tibia: a rare case report and genetic profile analysis.
Zheng C; Wang Y; Luo Y; Pang Z; Zhou Y; Min L; Tu C
BMC Musculoskelet Disord; 2022 Jan; 23(1):74. PubMed ID: 35057767
[TBL] [Abstract] [Full Text] [Related]
11. Expression of Programmed Cell Death-L1 (PD-L1) Protein and Mismatch Repair Mutations in Orbital Tumours-a Pilot Study.
AlSemari MA; Strianese D; Abu Safieh L; Al Hussain H; Abedalthagafi M; Edward DP
Eur J Ophthalmol; 2022 Sep; 32(5):3097-3102. PubMed ID: 34931541
[TBL] [Abstract] [Full Text] [Related]
12. Identification of ARGLU1 as a potential therapeutic target for gastric cancer based on genome-wide functional screening data.
Li F; Li J; Yu J; Pan T; Yu B; Sang Q; Dai W; Hou J; Yan C; Zang M; Zhu Z; Su L; Li YY; Liu B
EBioMedicine; 2021 Jul; 69():103436. PubMed ID: 34157484
[TBL] [Abstract] [Full Text] [Related]
13. Mismatch repair deficiency is rare in bone and soft tissue tumors.
Lam SW; Kostine M; de Miranda NFCC; Schöffski P; Lee CJ; Morreau H; Bovée JVMG
Histopathology; 2021 Oct; 79(4):509-520. PubMed ID: 33825202
[TBL] [Abstract] [Full Text] [Related]
14. PD‑L1 and IDO‑1 expression in undifferentiated pleomorphic sarcoma: The associations with tumor infiltrating lymphocytes, dMMR and HLA class I.
Ishihara S; Yamada Y; Iwasaki T; Yoshimoto M; Toda Y; Kohashi K; Yamamoto H; Matsumoto Y; Nakashima Y; Oda Y
Oncol Rep; 2021 Jan; 45(1):379-389. PubMed ID: 33155664
[TBL] [Abstract] [Full Text] [Related]
15. Primary intramucosal synovial sarcoma of the sigmoid colon in a patient with a germline mutation in the msh2 gene: A case report.
Shigematsu Y; Yamashita K; Takamatsu M; Tanizawa T; Togashi Y; Nakajima T; Chino A; Kawachi H; Takeuchi K
Pathol Int; 2020 Dec; 70(12):1015-1019. PubMed ID: 32940945
[TBL] [Abstract] [Full Text] [Related]
16. Comprehensive Immuno-Molecular Profiles for Liposarcoma: Roles of Programmed Death Ligand 1, Microsatellite Instability, and PIK3CA.
Jeon HM; Lee JS; Kim SH; Yun KH; Park KH; Jeon MK; Lee YH; Yoon HI; Suh JS; Hur H; Kim KS; Kim S; Kim SH; Kim HS
Oncology; 2020; 98(11):817-826. PubMed ID: 32892196
[TBL] [Abstract] [Full Text] [Related]
17. DNA Mismatch Repair-deficient Endometrial Carcinosarcomas Portend Distinct Clinical, Morphologic, and Molecular Features Compared With Traditional Carcinosarcomas.
Segura SE; Pedra Nobre S; Hussein YR; Abu-Rustum NR; Weigelt B; Soslow RA; DeLair DF
Am J Surg Pathol; 2020 Nov; 44(11):1573-1579. PubMed ID: 32804882
[TBL] [Abstract] [Full Text] [Related]
18. Integrated case-control and somatic-germline interaction analyses of soft-tissue sarcoma.
Hu F; Yu Y; Chen JS; Hu H; Scheet P; Huff CD
J Med Genet; 2021 Mar; 58(3):145-153. PubMed ID: 32447321
[TBL] [Abstract] [Full Text] [Related]
19. Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients With Osteosarcoma.
Mirabello L; Zhu B; Koster R; Karlins E; Dean M; Yeager M; Gianferante M; Spector LG; Morton LM; Karyadi D; Robison LL; Armstrong GT; Bhatia S; Song L; Pankratz N; Pinheiro M; Gastier-Foster JM; Gorlick R; de Toledo SRC; Petrilli AS; Patino-Garcia A; Lecanda F; Gutierrez-Jimeno M; Serra M; Hattinger C; Picci P; Scotlandi K; Flanagan AM; Tirabosco R; Amary MF; Kurucu N; Ilhan IE; Ballinger ML; Thomas DM; Barkauskas DA; Mejia-Baltodano G; Valverde P; Hicks BD; Zhu B; Wang M; Hutchinson AA; Tucker M; Sampson J; Landi MT; Freedman ND; Gapstur S; Carter B; Hoover RN; Chanock SJ; Savage SA
JAMA Oncol; 2020 May; 6(5):724-734. PubMed ID: 32191290
[TBL] [Abstract] [Full Text] [Related]
20. Whole-genome sequencing of synchronous thyroid carcinomas identifies aberrant DNA repair in thyroid cancer dedifferentiation.
Paulsson JO; Backman S; Wang N; Stenman A; Crona J; Thutkawkorapin J; Ghaderi M; Tham E; Stålberg P; Zedenius J; Juhlin CC
J Pathol; 2020 Feb; 250(2):183-194. PubMed ID: 31621921
[TBL] [Abstract] [Full Text] [Related]
[Next]
